Summary. In normal subjects during 24-hours saline infusion, plasma prolactin showed a number of small rises during day and night. The mean night-time level was significantly higher than the day-time level (8.2 +0.6 ng/ml as against 4.7 +_0.5 ng/ml). In 12 insulindependent diabetics the 24 h plasma prolactin pattern was identical to that found in normals. Somatostatin infusion (4 mg/24 h in normals; 2-6 mg/24 h in diabetics) had no effect on the 24 h plasma prolactin pattern in either normals or in diabetics.
Prolactin has been considered a diabetogenic hormone, because injection into dogs results in hyperglycaemia [1] and because endogenous hyperprolactinaemia in humans is accompanied by glucose intolerance in spite of hyperinsulinaemia [2] .
An early study suggested that plasma prolactin was elevated in some diabetic patients, especially those without or with only mild retinopathy [3] .
Somatostatin inhibits the in vitro secretion of prolactin from anterior pituitary cells in monolayer cultures [4, 5] . However, the basal prolactin secretion and the secretion induced by insulin, arginine and TRH in normal man has not been shown to be inhibited by somatostatin [6] [7] [8] [9] .
The present study was performed to determine the diurnal plasma prolactin level in normals and juvenile diabetics during 'daily life' conditions, and to investigate the effect of somatostatin infusion on these levels.
Material and Methods
The control subjects were four healthy, young, non-obese, male medical students. The diabetic group consisted of 12 young, nonobese, male subjects with juvenile type diabetes. They received insulin in one or two daily doses during the experiment. None of them had signs or symptoms of diabetic angiopathy. Full details of the subjects studied and experimental procedure are given in an earlier paper [10] .
On the day of experiment, indwelling catheters were inserted bilaterally in antecubital veins for blood sampling and infusion of saline or somatostatin. The ex~periment started at 0800 h. Blood was drawn hourly during the following 51 hours. Saline (0.154 tool/l) (500 ml) was infused during the first 24 hours. Cyclic somatostatin (dissolved in 500 ml saline) was infused during the following 24 hours. During the last three hours no infusion was given. Control subjects received a total dose of 4 mg somatostatin. Four diabetics received 2 mg somatostatin, four received 4 mg and four 6 mg. During the study the subjects were confined to bed, they were allowed to sleep only at night. None of the subjects received any medication except insulin. They all received a standard diet. Plasma glucose was measured by a glucose oxidase method, and plasma prolactin by radioimmunoassay [11] . Paired Student's t-test were used for statistical analysis of differences between saline and somatostatin experiments. Student's t-test was used for determination of differences between normal subjects and diabetics. Figure 1 shows the mean plasma prolactin concentration in the four normal subjects and the 12 juvenile diabetics during the 24 hour saline infusion period (upper two curves) and during the 24 hour somatostatin infusion, followed by the three hour control period (lower two curves). In both normals and diabetics during saline infusion plasma prolactin showed a number of small rises during the day and night. The night-time concentration (Table 1) The 24 h pattern observed is similar to that shown earlier in normal man [12, 13] .
Results
There are few reports about prolactin in diabetes mellitus. Plasma prolactin concentrations have been found to be increased in single samples from a small series of diabetic patients without or with only simple retinopathy compared to normal concentrations in diabetics with severe retinopathy [3] . This finding, however, was not confirmed in a larger study, where samples were obtained every 4th hour during a 24 h period [14] and in another study measuring basal and TRH stimulated prolactin concentrations [15] . In both studies plasma prolactin was found within normal limits in patients with and without retinopathy.
Diabetic ketoacidosis is accompanied by increased plasma prolactin concentrations, which decreases during insulin treatment [11] .
It can be concluded that plasma prolactin levels are normal in diabetic patients without retinopathy in ordinary metabolic control conditions. This is in contrast to the elevated plasma growth hormone levels found in diabetic patients [16, 17] .
Somatostatin infusion had no effect on plasma prolactin when studied during a 24 h period of 'normal life' in diabetics and in normals. This finding is in accordance with short-term infusion experiments in normal man where the basal secretion of prolactin and the secretion induced by insulin, arginine and TRH are not inhibited by somatostatin [6] [7] [8] [9] .
